Arthropod borne flaviviral diseases are a major public health concern in the tropics. However, the majority of cases are associated with Dengue virus (DENV), Yellow Fever virus (YFV), West Nile virus (WNV) and Chikungunya virus (CHIKV) infections. Despite their profound clinical and economic impact among large sections of the population there is a lack of effective treatment against these diseases. A large number of plants are available in nature, which may act as a source for lead molecules against various diseases including arthropod borne flaviviral infections. In this review we discuss various crude extracts as well as purified compounds from natural sources with promising anti-DENV, YFV, WNV and CHIKV activity.
Flaviviruses are enveloped, single-stranded RNA viruses that belong to the family Flaviviridae. The genus Flavivirus contain viruses that are transmitted by either mosquitoes or ticks (arthropod-borne) [1] . Currently, more than 70 flaviviruses have been reported. All those of human importance belong to the arthropod-borne group. Some most pathogenic arthropod borne flavorviruses with major public health impact include Dengue virus (DENV), Yellow Fever virus (YFV), West Nile Virus (WNV) and Chikungunya Virus (CHIKV). More than 500,000 people in Asian and Latin American countries with severe dengue require hospitalization each year [2] .A Chikungunya epidemic occurred in several states of India in 2005-2006 affecting about 1.3 million people with an attack rate of 45% [3] . Another virus of concern is the Yellow Fever Virus (YFV). YFV has many features in common with other hemorrhagic fevers, but is characterized by more severe liver injury. Despite the availability of a highly efficacious vaccine, YFV is still a leading cause of hemorrhagic fever worldwide. More than 200,000 people are affected by YFV every year with more than 15% fatality [4] . Japanese encephalitis (JE) is another leading cause of viral encephalitis in Asia with annual fatality of about 10,000 [5] . Besides the above viruses, WNV may also cause severe neurological complications in 20% of the infected individuals [6] . Despite the clinical impact and public health concerns of infections with flaviviruses, most treatments are supportive, mainly constituting good medical management and nursing care, while effective therapy against these viruses is still a distant reality.
Flavivirus Structure and Replication
Flaviviruses are generally 50 nm in diameter and have icosahedral symmetry. The core of the virus is the nucleocapsid, which contains a single-stranded, non-segmented, positive polarity 11-Kb genome [1] along with structural C proteins. The nucleocapsid is surrounded by a viral envelope, a lipid bilayer taken from the host cell. Embedded in the viral envelope are E and M proteins that span the lipid bilayer. Identical copies of the envelope protein are attached to the surface of the membrane by a short transmembrane segment. These proteins control the entry of the virus into human cells. In mature virions, protein E is organized as a head-to-tail orientated homodimer, which lies in sets of three, nearly parallel to each other and to the viral surface, forming a smooth ''herringbone'' configuration. However, DENV virion lacks a true T = 3 symmetry, which means that the three E monomers present in each icosahedral asymmetric unit exist in three chemically distinct environments and may, therefore, play a distinct role in different stages of the infection. Virion RNA has a cap at the 5' end but a poly (A) sequence is not present at the 3' end. Methylation of the 5' end is important for viral replication and translation while the 3' end is involved in circularization of genome by interacting with the 5' end [7] .
Host cells for flaviviral infection include monocytes, macrophages and dendritic cells [8] . The virus attaches to the cell surface, mediated by the E protein, and enters the cell by receptor-mediated endocytosis [8] . Low pH in the endosomal compartment triggers fusion of the viral and host cell membrane mediated by structural reorganization of E protein, which leads to the release of the nucleocapsid and viral RNA into the cytoplasm [9] . Translation of the RNA generates a polyprotein that is co-translationally and posttranslationally processed by the virus-encoded serine protease, NS2B/NS3, and by host-encoded proteases, including signalase and furin to produce three structural proteins involved in the formation of capsid [C], membrane [prM], and envelope [E], and seven nonstructural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5) involved in viral replication [10] .
Anti-flaviviral natural compounds
There are several advantages to the screening of natural products for drug discovery. A large proportion of natural products in drug discovery has stemmed from their diverse structural characteristics [11] and many of these secondary metabolites have become promising lead molecules [12] .Synthetic drugs are typically the result of numerous structural modifications over the course of an extensive drug discovery program, making it an extremely time consuming and expensive process, while a natural product might go straight from 'hit' to drug. Natural compounds and crude plant extracts acting against various flaviviruses are discussed in this review.
Flavonoids: Flavonoids belong to a group of natural substances with variable phenolic structures and are found in, for example, vegetables, grains, bark, root, tea, and wine [13] . These benzopyrone derivatives are widely distributed throughout the plant kingdom. These polyphenolic compounds, of low molecular weight, exhibit diverse biological activities, as reviewed elsewhere [14] . It is of particular interest to note that flavonoids have also been shown to possess antiviral activity. One stage of viral replication that may be inhibited by flavonoids is viral RNA synthesis. Compounds like rutin, quercetin, and ellagic acid have been found to inhibit DENV2 virus replication in C6/36 cells. Comparing IC 50 values, rutin was found to be more active than quercetin [15] . In another group of studies, flavanols have shown antiviral and immunomodulatory action. Flavanols isolated from non-ripe apple peel were tested for their capacity to reduce dengue viral titers and were found to exhibit direct antiviral activity on human peripheral blood mononuclear cells (PBMCs).
Flavanols have also been shown to increase sensitivity to type-1 interferon, which may be responsible for its anti-viral activity [16] .
In vitro antiviral activity of the flavonoids, baicalein and quercetin have been evaluated against Japanese encephalitis virus (JEV) replication in Vero cells. Anti-JEV activities of these compounds were examined at different stages of the JEV replication cycle. The effect of the compounds on viral replication was determined by foci forming unit reduction assays (FFURA) and quantitative RT-PCR. Baicalein showed potent antiviral activity with an IC 50 of 14.28 μg/mL, whereas quercetin exhibited weak anti-JEV effects (IC 50 = 212.1 μg/mL). Baicalein also exhibited significant effect against JEV adsorption (IC 50 = 7.27 μg/mL) and direct extracellular virucidal activity, while quercetin did not show any such effect [17] . Kaempferol seemed to inactivate the virus by binding with the frame shift RNA of JEV [18] Natural polysaccharides: Diverse natural carrageenans have shown potent antiviral activity against enveloped viruses, including herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) and DENV [19] . These viruses interact with the glycosaminoglycan, heparin sulfate for their initial binding to the host cell. The carrageenans isolated from Meristiella gelidium, a red seaweed, were found to be among the most potent sulfated polysaccharides. The antiviral action of sulfated polysaccharides has been attributed to the interaction of the polysaccharide with the viral glycoprotein, thus preventing the entry of the virus into the host cell, the same type of interaction that occurs between viral glycoproteins and glycosaminoglycans, particularly with heparan sulfate, naturally present on the host cell surface. Similarly, the galactomannans from Mimosa scabrella (BR) and Leucaena leucocephala (LL) have shown good inhibitory actions on YFV (BeH111 strain) and DENV1 (Hawaii strain) [20] .
Glycosides:
In an effort to identify novel inhibitors of CHIKV and DENV replication, a systematic study of 820 ethyl acetate extracts of Madagascan plants was performed in a virus-cell-based assay for CHIKV and DENV NS5 RNA-dependent RNA polymerase (RdRp) assay. The extract obtained from the stem bark of Flacourtia ramontchi showed significant activity in both assays. Six new phenolic glycosides, named flacourtosides A−F, phenolic glycosides itoside H, xylosmin, scolochinenoside D, poliothrysoside and betulinic acid 3β-caffeate were obtained using the bioassayguided isolation process. Significant antiviral activity against CHIKV was observed with betulinic acid 3β-caffeate (IC 50 = 0.85 ± 0.1 μM) and to a lesser extent with flacourtosides A and E, as well as with scolochinenoside D and flacourtosides A−F [27] .
Alkaloids: Castanospermine is an indolizidine alkaloid derived from the black bean or Moreton bay chestnut tree Castanospermum australae. In cells, castanospermine acts as an endoplasmic reticulum α-glucosidase I inhibitor [22] and reduces infection of a subset of enveloped RNA and DNA viruses in vitro. DENV1 inhibition results from misfolding of structural glycoproteins of the virus. Oxindole alkaloids from Uncaria tomentosa induced apoptosis, favoring elimination of virus infected cells. Also, in vitro studies on DENV infected human monocytes revealed their IFN-α inhibitory effect [21] . Lycorine, is an alkaloid found in several plants, such as daffodil (Narcissus pseudonarcissus) and bush lily (Clivia miniata). A number of biological activities have been reported for lycorine, including inhibition of protein and DNA synthesis in poliovirus and HSV-1. Lycorine potently inhibit flaviviruses in cell culture. At a 1.2 μM concentration, lycorine reduced viral titers of WNV, dengue, and YFV by 10 2 to 10 4 -fold [23] . Another study on palmatine, a principal compound belonging to the protoberberine class of isoquinoline alkaloids from Coptis chinensis Franch (Ranunculaceae), has shown its dose dependent inhibitory effect on viral NS2B-NS3 protease [24] .
Emetine, an ipecac alkaloid, is known to inhibit protein and nucleic acid synthesis. Emetine treatment of DENV-infected human cell lines may substantially reduce viral titer, as revealed by both plaque and immune fluorescence assays. A time-course study also showed the involvement of emetine inhibition during the early stages of DENV replication. Emetine probably inhibits DENV at the postentry phase during viral replication [25] . Studies on the activity of aloe-emodin against JEV in TE 671 cells showed a dose-dependent induction of IFN-γ, which may prevent viral replication in macrophages. Aloe-emodin induces the activation of interferon stimulated response elements (ISRE) as well as up-regulation of IFN-stimulated gene expression, such as the dsRNA-activated protein kinase and the 2' 5' oligoisoadenylate synthase, which may all lead to prevention of viral replication [26] .
Terpenoids: Trigowiin A is a new tigliane diterpenoid from species of Trigonostemon. Its evaluation in a CHIKV virus-cell-based assay has revealed its selective antiviral activity [29] .
Squalamine: Squalamine was first discovered in the tissues of the dogfish shark (Squalus acanthias) as a broad-spectrum antimicrobial agent in 1993. It can strongly displace membranebound cationic proteins such as Rac1, a ρ-GTPase recruited to the inner leaflet of the eukaryotic cytoplasmic membrane for actin remodeling during endocytosis. To determine the antiviral activity of squalamine against dengue virus, in vitro studies on a line of human microvascular endothelial cells (HMEC-1) were performed. Dengue virus, which infects the microvascular and hepatic endothelium, has been recently shown to engage in the Rac1dependent pathway during its entry phase. The early fusion process is believed to involve interactions between the viral E protein and anionic phospholipids [30] . At concentrations between 20 and 60 μg/mL, squalamine has been shown to inhibit a broad array of growth factor-induced, actin-dependent responses in endothelial cells, including cell migration, cell division, and vascular tube formation. At a concentration of 40 μg/mL, squalamine inhibited about 60% DENV2 infection with complete inhibition observed at 100 μg/mL [31] .
Phenols: Zosteric acid, a phenolic acid derived from Zostera marina, was found to interfere with the binding of virus to the receptor required for DENV entry into the host cell [32] .
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Natural Product Communications Vol. 8 (10) 2013 1489 Snake venom: Snake venoms have been shown to have antibacterial, antiparasitic and antiviral activities [33] . The venom of Crotalus durissus terrificus, a South American rattlesnake, contains several biologically active molecules. Studies have shown its potential antiviral activity against YFV and DENV. Crude venoms (yellow and white) containing crotoxin and Phospholipase A2 could inhibit YFV and DENV replication in VERO E6 cells and presented high selectivity indexes. Most potent inhibition of viral replication was observed in the virucidal and adsorption assays, indicating that the action occurs at the initial steps of the replication cycle [34] . L-Amino acid oxidase (LAAO), a flavoenzyme obtained from the venom of Bothrops jararaca, also shows anti-DENV activity. Cells infected with DENV3 and treated with LAAO isolated from the venom of Bothrops jararaca, showed a reduction in viral load compared with viral infected untreated cells [35] Antibiotics Geneticin is an aminoglycoside antibiotic. It is produced by Micromonospora rhodorangea. Geneticin may directly inhibit DENV through specifically interacting with the viral structural or nonstructural proteins or binding to viral RNA [36] .
Narasin is an ionophore that belongs to the polyether antibiotic family synthesized by the bacterium, Streptomyces aureofaciens. Narasin has been shown to disrupt the early phase of DENV's replication cycle [37] .
Anisomycin has been reported to show anti-viral action against JEV. It is an antibiotic produced by Streptomyces griseolus, which inhibits viral protein synthesis [38] Virucidal action of essential oil extracts: The precise mechanism of the virucidal action of essential oils is still not fully understood. Previous studies indicate that the inhibitory effect occurs during the adsorption and penetration steps of the virus into the cell. Components present in the oil may interfere with the virion envelope structure masking the E and M viral proteins, which are necessary for adsorption and entry into the host cell [39, 40] . Antiflaviviral activity against DENV has been reported for the essential oils of Artemisia douglasiana, Eupatorium patens [41] , Lippia citriodora and L. alba [42] .
Crude extracts showing anti-flaviviral action:
The leaf extract of Azadirachta indica Juss has a stimulating or growth enhancing effect in vitro. Studies have revealed that the inhibitory effect of the aqueous extract of neem leaves on DENV2 is due to suppression of viral entry and reduction in viral replication [43] .
The activity of the leaf extract of Hippophae rhamnoides (Seabuckthorn, SBT; Family Elaeagnaceae) has been evaluated in DENV2 infected macrophages. Infected cells treated with SBT leaf extract led to decrease in TNF-α and increase in IFN-γ levels, without altering cell viability, the activity being comparable with that of the anti-viral drug, ribavirin. Anti-dengue activity of SBT was further validated using a plaque assay [44] . The anti-dengue activity of SBT could be due to hiporamin (poly-phenolic complex of tannins), which possesses a wide spectrum of anti-viral activity. Tannins are potent inhibitors of polyADP-ribose glucohydrolase, an enzyme which may regulate gene transcription [45] .
The galls of Quercus lusitanica have various medicinal properties including, anti-diabetic, astringent and anti-pyretic activities [46] . Studies using Q. lusitanica extract on the C6/36 cell line has shown its ability to downregulate NS1 protein expression in DENV2infected C6/36 cells. The nonstructural NS1 is a glycoprotein present in all flaviviruses, and appears to be essential in early stages of viral replication and viability [47] .
The ethyl acetate extract obtained from Anacolosa pervilleana has shown pronounced inhibition of DENV NS5 polymerase acting at the RdRp domain (100% inhibition at 10 μg/mL) [28] .
The ethanolic extract and sub-fractions (EtOAc, EtOAc, MeOH) from leaves and fruits of Distictella elongata (Bignoniaceae) and isolated compounds, including, pectolinarin and acacetin-7-Orutinoside have shown anti-DENV2 activity [48] .
Kaempferia parviflora Wall. ex. Baker (leaves and stem, Zingiberaceae), Ellipeiopsis cherrevensis Fries (Annonaceae) and Stemona tuberosa Lour. (Stemona leaves and stem, Stemonaceae) have also been screened for their potential anti DENV2 properties. Although K. parviflora and S. tuberosa lacked protective and therapeutic effects, their inhibitory actions on DENV2 activity was shown to be virucidal in a dose dependent manner. [49] Conclusions: Arthropod borne viral diseases are a major public health challenge, especially in regions with tropical and subtropical climates. Despite profound clinical and economic impact of flavivirus infections among large sections of the population, most treatments constitute medical management, while effective therapy is still elusive. A large number of plants are available from Nature, which may act as a source of lead antiflaviviral compounds (Table  1) . These natural compounds, after appropriate pharmacological and toxicological screening, may eventually lead to new therapeutics for arthropod borne viral diseases. [59, 65] 
